Emergence of Chemotherapy Related Hyperglycemia in nOn-diabetic Patients (ECHO)

National Cancer Center (NCC)

Status: Unknown

Conditions: Breast Cancer; Malignant Lymphoma; Colon Cancer; Cancer

Treatments: Drug: Chemotherapy

Study type: Observational

Funder types: Other

Identifiers

NCT03062072

NCC2015-0040 (Other Identifier)

ECHO

Details and patient eligibility

About

To assess chemotherapy related hyperglycemia in non-diabetic patients, the investigators will assess the incidence of hyperglycemia and analyze co-medications and risk factors.

Enrollment: 300 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with cancers (colorectal, breast) who treated with curative intents and ones with malignant lymphoma who are expected to achieve complete remission with chemotherapy (mainly, CHOP regimen)
• Patients without history of diabetes mellitus
• Normal glucose tolerance, as defined in the protocol

Exclusion criteria

• Patients with diabetes mellitus or hyperglycemia, as defined in the protocol